These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10228142)

  • 41. The Spacehaler for delivery of salbutamol: a comparison with the standard metered-dose inhaler plus Volumatic spacer device.
    Gunawardena KA; Sohal T; Jones JI; Upchurch FC; Crompton GK
    Respir Med; 1997 May; 91(5):311-6. PubMed ID: 9176650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals.
    Derom E; Borgström L; Van Schoor J; Löfroos AB; Pauwels R
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1398-402. PubMed ID: 11704585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Formoterol by pressurized metered-dose aerosol or dry powder on airway obstruction and lung hyperinflation in partially reversible COPD.
    Brusasco V; Canonica GW; Dal Negro R; Scano G; Paggiaro P; Fabbri LM; Barisione G; D'Amato G; Varoli G; Baroffio M; Milanese M; Mereu C; Crimi E
    J Aerosol Med Pulm Drug Deliv; 2011 Oct; 24(5):235-43. PubMed ID: 21689019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism.
    Lavorini F; Geri P; Mariani L; Marmai C; Maluccio NM; Pistolesi M; Fontana GA
    Br J Clin Pharmacol; 2006 Oct; 62(4):403-11. PubMed ID: 16995861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics.
    Rosenborg J; Bengtsson T; Larsson P; Blomgren A; Persson G; Lötvall J
    Eur J Clin Pharmacol; 2000 Aug; 56(5):363-70. PubMed ID: 11009043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
    Baronti A; Grieco A; Vibelli C
    Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J; Ankerst J
    Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
    Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose-response to salbutamol via a novel palm sized nebuliser (Aerodose Inhaler), conventional nebuliser (Pari LC Plus) and metered dose inhaler (Ventolin Evohaler) in moderate to severe asthmatics.
    Lipworth BJ; Sims EJ; Taylor K; Cockburn W; Fishman R
    Br J Clin Pharmacol; 2005 Jan; 59(1):5-13. PubMed ID: 15606434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients.
    Rosenborg J; Larsson R; Rott Z; Böcskei C; Poczi M; Juhász G
    Respir Med; 2002 Jun; 96(6):412-7. PubMed ID: 12117040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Similar bronchodilation with formoterol delivered by aerolizer or turbuhaler.
    Lötvall J; Mellén A; Arvidsson P; Palmqvist M; Radielovic P; Kottakis J; Pfister P
    Can Respir J; 1999; 6(5):412-6. PubMed ID: 10572207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler DPI.
    Newhouse MT; Patel P; Parry-Billings M
    Eur Respir J; 2003 May; 21(5):816-20. PubMed ID: 12765427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reducing electrostatic charge on spacer devices and bronchodilator response.
    Wildhaber JH; Waterer GW; Hall GL; Summers QA
    Br J Clin Pharmacol; 2000 Sep; 50(3):277-80. PubMed ID: 10971314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
    Piquet J; Zuck P; Dennewald G; Dugue P; Grivaux M; Brun P; Severac JC; Ostinelli J; Cheeseman KH
    Adv Ther; 1996; 13(1):38-50. PubMed ID: 10172710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of inspiratory capacity on bronchodilatation via Turbuhaler or pressurized metered-dose inhaler in asthmatic children: a comparison.
    Hirsch T; Peter-Kern M; Koch R; Leupold W
    Respir Med; 1997 Jul; 91(6):341-6. PubMed ID: 9282236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of bronchodilating effects of two salbutamol dry powder inhalers in asthmatic patients.
    Laurikainen K; Silvasti M; Calderon P; Lins R; Rosillon D
    Arzneimittelforschung; 1997 Jan; 47(1):44-6. PubMed ID: 9037443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative efficacy of terbutaline sulphate delivered by Turbuhaler dry powder inhaler or pressurised metered dose inhaler with Nebuhaler spacer in children during an acute asthmatic episode.
    Drblik S; Lapierre G; Thivierge R; Turgeon J; Gaudreault P; Cummins-McManus B; Verdy I; Haddon J; Lee J; Spier S
    Arch Dis Child; 2003 Apr; 88(4):319-23. PubMed ID: 12651757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.